C2CA Stock Overview
Concord Medical Services Holdings Limited, an investment holding company, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Concord Medical Services Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.52 |
| 52 Week High | US$1.41 |
| 52 Week Low | US$0.33 |
| Beta | -0.17 |
| 1 Month Change | 36.24% |
| 3 Month Change | -36.42% |
| 1 Year Change | -59.13% |
| 3 Year Change | -82.83% |
| 5 Year Change | -77.01% |
| Change since IPO | -91.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| C2CA | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -9.6% | 5.4% | 1.7% |
| 1Y | -59.1% | 0.6% | 2.3% |
Return vs Industry: C2CA underperformed the German Healthcare industry which returned 1.9% over the past year.
Return vs Market: C2CA underperformed the German Market which returned 2.2% over the past year.
Price Volatility
| C2CA volatility | |
|---|---|
| C2CA Average Weekly Movement | 23.7% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: C2CA's share price has been volatile over the past 3 months.
Volatility Over Time: C2CA's weekly volatility has increased from 14% to 24% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 727 | Jianyu Yang | www.concordmedical.com |
Concord Medical Services Holdings Limited, an investment holding company, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates through two segments: Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.
Concord Medical Services Holdings Limited Fundamentals Summary
| C2CA fundamental statistics | |
|---|---|
| Market cap | €23.53m |
| Earnings (TTM) | -€38.38m |
| Revenue (TTM) | €69.30m |
0.3x
P/S Ratio-0.6x
P/E RatioIs C2CA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| C2CA income statement (TTM) | |
|---|---|
| Revenue | CN¥537.40m |
| Cost of Revenue | CN¥614.01m |
| Gross Profit | -CN¥76.61m |
| Other Expenses | CN¥221.05m |
| Earnings | -CN¥297.66m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.86 |
| Gross Margin | -14.26% |
| Net Profit Margin | -55.39% |
| Debt/Equity Ratio | 174.9% |
How did C2CA perform over the long term?
See historical performance and comparison